汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A(017894)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
62,196,400 |
104,077,000 |
77,370,200 |
35,490,000 |
41,880,200 |
67.34% |
2023/12/31 |
14,713,700 |
62,196,400 |
66,480,600 |
18,997,900 |
47,482,700 |
322.71% |
2023/12/31 |
28,973,800 |
62,196,400 |
37,157,300 |
3,934,650 |
33,222,650 |
114.66% |
2023/9/30 |
21,239,500 |
28,973,800 |
21,030,600 |
13,296,300 |
7,734,300 |
36.41% |
2023/6/30 |
14,713,700 |
21,239,500 |
8,292,750 |
1,766,930 |
6,525,820 |
44.35% |
2023/6/30 |
14,915,600 |
21,239,500 |
7,910,720 |
1,586,800 |
6,323,920 |
42.4% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。